Strict Glucose Control of Pediatric Intensive Care Unit (ICU) Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2004-12-31

Study Completion Date

2004-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study objective is to improve morbidity and mortality of high-risk critically ill children. Our hypothesis is that a strict ICU glucose control protocol will decrease morbidity and mortality associated with hyperglycemia in a population of high-risk critically ill pediatric patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry

NCT01116674

Hypoglycemia Hyperglycemia

COMPLETED

Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit

NCT00240149

Hyperglycemia

COMPLETED NA

Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children

NCT00487006

Critical Illness Hyperglycemia

COMPLETED NA

Tight Glycemic Control With Intensive Insulin Therapy in PICU

NCT00214916

Critical Illness

UNKNOWN PHASE2

Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial

NCT01116752

Pediatric Patient (1m-21y) ICU Admission Hyperglycemia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Failure Cardiovascular Failure Sepsis Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Strict Glucose Control

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Vasoactive infusion (e.g. dopamine, epinephrine, norepinephrine) and/or
* Invasive mechanical ventilation
* Age between 1 mo and 21 yrs

Exclusion Criteria

* Type I diabetes mellitus
* Have an illness that requires insulin daily
* Recipients of solid organ transplants
* Participation in an experimental trial that might affect outcome
* Post-operative patients with planned extubation upon recovery
* Patients on a dopamine infusion of less than 3 mcg/kg/minute

Minimum Eligible Age

1 Month

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No